Oncogenic collaboration of the cyclin D1 (PRAD1, bcl-1) gene with a mutated p53 and an activated ras oncogene in neoplastic transformation

Japanese Journal of Cancer Research

Volumn 87, Issue 5, 1996, Pages 459-465

  Uchimaru, Kaoru ^a   Endo, Koichi ^b   Fujinuma, Haruko ^a   Zukerberg, Lawrence ^c   Arnold, Andrew ^c   Motokura, Toru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Cyclin D1; p53; ras; Transfection experiment; Transformation

Indexed keywords

CYCLINE; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL TRANSFORMATION; CONTROLLED STUDY; FETUS; FIBROBLAST; GENE AMPLIFICATION; GENE MUTATION; GENE REARRANGEMENT; GENETIC TRANSFECTION; NONHUMAN; NUDE MOUSE; ONCOGENE RAS; PLASMID; PRIORITY JOURNAL; RAT; TUMOR SUPPRESSOR GENE;

EID: 0029898476     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1996.tb00246.x     Document Type: Article

References (36)

1. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature, 344, 503-508 (1990).
2. Grana, X. and Reddy, E. P. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene, 11, 211-219 (1995).
3. Arnold, A., Kim, H. G., Gaz, R. D., Eddy, R. L., Fukushima, Y., Byers, M. G., Shows, T. B. and Kronenberg, H. M. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J. Clin. Invest., 83, 2034-2040 (1989).
4. Rosenberg, C. L., Kim, H. G., Shows, T. B., Kronenberg, H. M. and Arnold, A. Rearrangement and overexpression of D11S287E, a candidate oncogene on chromosome 11q13 in benign parathyroid tumors. Oncogene, 6, 449-453 (1991).
5. Motokura, T., Bloom, T., Kim, H. G., Juppner, H., Ruderman, J. V., Kronenberg, H. M. and Arnold, A. A novel cyclin encoded by a bcl1-linked candidate oncogene. Nature, 350, 512-515 (1991).
6. Rosenberg, C. L., Wong, E., Petty, E. M., Bale, A. E., Tsujimoto, Y., Harris, N. L. and Arnold, A. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc. Natl. Acad. Sci. USA, 88, 9638-9642 (1991).
7. Withers, D. A., Harvey, R. C., Faust, J. B., Melnyk, O., Carey, K. and Meeker, T. C. Characterization of a candidate bcl-1 gene. Mol. Cell. Biol., 11, 4846-4853 (1991).
8. Lammie, G. A., Fantl, V., Smith, R., Schuuring, E., Brookes, S., Michalides, R., Dickson, C., Arnold, A. and Peters, G. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1. Oncogene, 6, 439-444 (1991).
9. Schuuring, E., Verhoeven, E., Mooi, W. J. and Michalides, R. J. A. M. Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene, 7, 355-361 (1992).
10. Yoshida, T., Sakamoto, H. and Terada, M. Amplified genes in cancer in upper digestive tract. Semin. Cancer Biol., 4, 33-40 (1993).
11. Motokura, T. and Arnold, A. Cyclins and oncogenesis. Biochim. Biophys. Acta, 1155, 63-78 (1993).
12. Hunter, T. and Pines, J. Cyclins and cancer. II: cyclin D and CDK inhibitors come of age. Cell, 79, 573-582 (1994).
13. Finlay, C. A., Hinds, P. W., Tan, T.-H., Eliyahu, D., Oren, M. and Levine, A. J. Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol. Cell. Biol., 8, 531-539 (1988).
14. Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A. and Weinberg, R. A. Function of a human cyclin gene as an oncogene. Proc. Natl. Acad. Sci. USA, 91, 709-713 (1994).
15. Zhang, K., Chaillet, J. R., Perkins, L. A., Halazonetis, T. D. and Perrimon, N. Drosophila homolog of the mammalian jun oncogene is expressed during embryonic development and activates transcription in mammalian cells. Proc. Natl. Acad. Sci. USA, 87, 6281-6285 (1990).
16. Chen, C. and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol., 7, 2745-2752 (1987).
17. Hill, H. D. and Straka, J. G. Protein determination using bicinchoninic acid in the presence of sulfhydryl reagents. Anal. Biochem., 170, 203-208 (1988).
18. Lane, D. and Harlow, E. "Antibodies: a Laboratory Manual," pp. 471-510 (1988). Cold Spring Harbor Laboratory, Cold Spring Harbor.
19. Yang, W. I., Zukerberg, L. R., Motokura, T., Arnold, A. and Harris, N. L. Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia. Am. J. Pathol., 145, 86-96 (1994).
20. Motokura, T., Keyomarsi, K., Kronenberg, H. M. and Arnold, A. Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1/cyclin D1 proto-oncogene. J. Biol. Chem., 267, 20412-20415 (1992).
21. Danielpour, D., Dart, L. L., Flanders, K. C., Roberts, A. B. and Sporn, M. B. Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-β1 and TGF-β2) secreted by cells in culture. J. Cell. Physiol., 138, 79-86 (1989).
22. Eliyahu, D., Raz, A., Grass, P., Givol, D. and Oren, M. Participation of p53 cellular tumour antigen in transformation of normal embryonic cells. Nature, 312, 646-649 (1984).
23. Parada, L. F., Land, H., Weinberg, R. A., Wolf, D. and Rotter, V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature, 312, 649-651 (1984).
24. Jiang, W., Kahn, S. M., Zhou, P., Zhang, Y. J., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M. and Weinstein, I. B. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. Oncogene, 8, 3447-3457 (1993).
25. Lovec, H., Sewing, A., Lucibello, F. C., Muller, R. and Moroy, T. Oncogenic activity of cyclin D1 revealed through cooperation with Ha-ras: link between cell cycle control and malignant transformation. Oncogene, 9, 323-326 (1994).
26. Wang, T. C., Cardiff, R. D., Zukerberg, L., Lees, E., Arnold, A. and Schmidt, E. V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature, 369, 669-671 (1994).
27. Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar, S. D., Roussel, M. F. and Sherr, C. J. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev., 7, 1559-1571 (1993).
28. Taylor, W. R., Egan, S. E., Mowat, M., Greenberg, A. H. and Wright, J. A. Evidence for synergistic interactions between ras, myc and a mutant form of p53 in cellular transformation and tumor dissemination. Oncogene, 7, 1383-1390 (1992).
29. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z. and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69, 119-128 (1992).
30. Atadja, P., Wong, H., Veillete, C. and Riabowol, K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp. Cell Res., 217, 205-216 (1995).
31. Nagayama, K. and Watatani, M. Analysis of genetic alterations related to the development and progression of breast carcinoma. Jpn. J. Cancer Res., 84, 1159-1164 (1993).
32. Rosenwald, I. B., Lazaris-Karatzas, A., Sonenberg, N. and Schmidt, E. V. Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E. Mol. Cell. Biol., 13, 7358-7363 (1993).
33. Kitagawa, Y., Ueda, M., Ando, N., Shinozawa, Y., Shimizu, N. and Abe, O. Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal carcinoma. Cancer Res., 51, 1504-1508 (1991).
34. Borg, Å., Sigurdsson, H., Clark, G. M., Fernö, M., Fuqua, S. A. W., Olsson, H., Killander, D. and McGurie, W. L. Association of INT2/HST1 coamplification in primary breast cancer with hormone-dependent phenotype and poor prognosis. Br. J. Cancer, 63, 136-142 (1991).
35. Tsuda, H., Hirohashi, S., Shimosato, Y., Teruyuki, H., Tsugane, S., Yamamoto, H., Miyajima, N., Toyoshima, K., Yamamoto, T., Yokota, J., Yoshida, T., Sakamoto, H., Terada, M. and Sugimura, T. Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1. Cancer Res., 49, 3104-3108 (1989).
36. Schuuring, E., Verhoeven, E., van Tinteren, H., Peterse, J. L., Nunnink, B., Thunnissen, F. B. J. M., Devilee, P., Cornelisse, C. J., van de Vijver, M. J., Mooi, W. J. and Michalides, R. J. A. M. Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer. Cancer Res., 52, 5229-5234 (1992).